Drugs / Neuroinduced Mesenchymal Stem Cells
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07467733 | Jun 2026 → Jun 2028 expected | cerebellar ataxia | Biocells Medical | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Neuroinduced Mesenchymal Stem Cells | “200,000,000 neuroinduced mesenchymal stem cells administered via intravenous infusion.” NCT07467733 ↗ |
| Route | Intravenous | “administered via intravenous infusion” NCT07467733 ↗ |